MEDICAL RECOMMENDATIONS

Archived 42: Recommendations on the use of Moderna Spikevax COVID-19 vaccine in children 6 months to 5 years of age [2022-07-14]

National Advisory Committee on ImmunizationImmunization2022Archived document

ASEM documentary overview

Official National Advisory Committee on Immunization document (2022) on “Archived 42: Recommendations on the use of Moderna Spikevax COVID-19 vaccine in children 6 months to 5 years of age [2022-07-14]”. NACI recommendations on the use of Moderna Spikevax COVID-19 vaccine in children 6 months to 5 years of age: Methods, clinical trial data, efficacy, immunogenicity, administration, safety, adverse events and more.

This overview helps you identify the document. Always consult the current official publication for clinical recommendations.

Official document